Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vila, J.
Right arrow Articles by Jimenez De Anta, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vila, J.
Right arrow Articles by Jimenez De Anta, M. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2002) 49, 471-477
© 2002 The British Society for Antimicrobial Chemotherapy

Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates

Jordi Vilaa,*, Anna Riberaa, Francesc Marcoa, Joaquim Ruiza, Josep Mensaa, Josep Chavesb, Gonzalo Hernandezb and M. Teresa Jimenez De Antaa

a Institut Clinic d'Infeccions i Immunologia, IDIBAPS, Facultat de Medicina, Universitat de Barcelona, Villarroel, 170, 08036 Barcelona; b Parke-Davis, S.L., Poligono Industrial Manso Mateu, s/n, 08820 El Prat de Llobregat, Spain

The in vitro activity of clinafloxacin was studied in comparison with ciprofloxacin, levofloxacin, moxifloxacin, nalidixic acid, sparfloxacin and trovafloxacin against Acinetobacter baumannii clinical isolates. Clinafloxacin showed a MIC90 of 4 mg/L, whereas the remaining quinolones showed a MIC90 equal to or higher than 16 mg/L. MIC50 determination in the presence of reserpine resulted in a two-fold decrease, except for trovafloxacin, which decreased four-fold, and for moxifloxacin and nalidixic acid, which did not change. The effect of reserpine was most pronounced among strains with a low level of resistance to quinolones. The MIC of clinafloxacin for strains with no mutation in either gyrA or parC genes ranged from 0.008 to 0.25 mg/L. In strains with a single mutation at amino acid codon Ser83 of the gyrA gene, the MIC of clinafloxacin ranged from 0.12 to 1 mg/L, whereas strains with a double mutation, one in the gyrA gene and another in the parC gene, showed a range of MIC of clinafloxacin from 1 to 8 mg/L. Therefore, clinafloxacin shows good activity against strains carrying a single mutation in the gyrA gene, and hence a second mutation is required for the microorganism to express resistance.

* Corresponding author. Tel: 34-93-2275522; Fax: 34-93-2275454; E-mail: vila{at}medizina.ub.es


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
J. Vila, S. Marti, and J. Sanchez-Cespedes
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
J. Antimicrob. Chemother., June 1, 2007; 59(6): 1210 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
X. Valles, A. Marcos, M. Pinart, R. Piner, F. Marco, J. M. Mensa, and A. Torres
Hospitalized Community-Acquired Pneumonia Due to Streptococcus pneumoniae: Has Resistance to Antibiotics Decreased?
Chest, September 1, 2006; 130(3): 800 - 806.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. P. Spence and K. J. Towner
Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii
J. Antimicrob. Chemother., October 1, 2003; 52(4): 687 - 690.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Ribera, J. Ruiz, and J. Vila
Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii
Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2310 - 2312.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. Wisplinghoff, M. Decker, C. Haefs, O. Krut, G. Plum, and H. Seifert
Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of Acinetobacter baumannii
J. Antimicrob. Chemother., January 1, 2003; 51(1): 177 - 180.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.